Sat.Apr 06, 2024 - Fri.Apr 12, 2024

article thumbnail

Key Facts GPs Should Know About GLP-1 Analogs

Family Medicine Initiative

Demand for new obesity medications like semaglutide (GLP-1 analogs) is high, but availability is low. So, which patients should get them first? What are the true benefits and side effects? Patients ask me these questions fairly often, so I know it’s important for GPs to know the key facts. I therefore reviewed the main research studies and guidelines and tried to summarize them briefly and clearly in this article. 1.

Diabetes 130
article thumbnail

Reflections On Healthcare Access

University of Utah Family Medicine Residency

by Hendrik Stegall, MD Utahns can’t find a doctor. That was the highlight of a recent Salt Lake Tribune article, which suggested that many parts of Utah have fewer than one MD per 1,000 residents.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Episode 328 – Clinical Unknown – Alec & Austin discuss Lauren’s case

The Clinical Problem Solvers

[link] Débora and Noah bring back the Clinical Unknown Series! To kick off the first episode, we host Alec and Austin, who discuss a case presented by Laure. Embark on this diagnostic journey with us!

Clinic 52
article thumbnail

OPQ’s 2023 Annual Report: an Upbeat Review of CDER’s Quality Efforts

FDA Law Blog

By John W.M. Claud — CDER’s Office of Pharmaceutical Quality (OPQ) issued its 2023 Annual Report last week, and it’s an upbeat assessment of the Office’s policy and outreach efforts. Last year, OPQ saved a more quantitative analysis of its efforts for the other yearly publication it put out, on the State of Pharmaceutical Quality. Again this year, the Annual Report that was released last week did not feature much in the way of specific quality issues.

article thumbnail

Challenges with Polypharmacy in the Geriatric Population - Clinical Correlations

Clinical Correlations

By Olivia Descorbeth Peer Reviewed As individuals advance in age, they tend to accumulate medical conditions that require a bevy of pharmaceutical treatments to manage. As a result, polypharmacy, generally defined as the use of five.

Clinic 52
article thumbnail

Provider Perspective: How a friend’s diagnosis inspired one doctor to do more cancer risk testing 

Myriad Genetics

Dr. Burton Brodsky had been an OB-GYN for years when his neighbor – and one of his wife’s closest friends – came to him with a question. She was wondering if she should be tested for this “BRCA gene.” Dr. Brodsky inquired about her family, and she told him that both sides of her family had an extensive history of ovarian cancer and breast cancer. “I told her she absolutely needed to be tested,” said Dr.

article thumbnail

8 Reasons Why Family Physicians are the Actual Stars of Medicine

Family Medicine Initiative

Family medicine is neither the most prestigious nor the highest paid medical profession. Is that appropriate, or should it be the opposite? Should GPs actually be treated as the stars of medicine? As a general practitioner and primary care researcher, it was always fascinating for me to delve into the scientific literature to investigate this issue.

article thumbnail

Ambivalence in Decision-Making: A Podcast with Joshua Briscoe, Bryanna Moore, Jennifer Blumenthal-Barby & Olubukunola Dwyer

GeriPal

Summary Transcript Summary Ambivalence is a tough concept when it comes to decision-making. On the one hand, when people have ambivalence but haven’t explored why they are ambivalent, they are prone to bad, value-incongruent decisions. On the other hand, acknowledging and exploring ambivalence may lead to better, more ethical, and less biased decisions.